6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

13 trials found

diseases per page:

Showing 1 to 10 of 13 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05589766 (ClinicalTrials.gov)	November 28, 2022	13/10/2022	N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease	N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease	Parkinson Disease	Dietary Supplement: Nicotinamide Riboside;Other: Placebo	Haukeland University Hospital	NULL	Recruiting	40 Months	100 Years	All	80	N/A	Norway
2	NCT03568968 (ClinicalTrials.gov)	May 15, 2020	14/6/2018	A Randomized Controlled Trial of Nicotinamide Supplementation in Early Parkinson's Disease	A Randomized Controlled Trial of Nicotinamide Supplementation in Early Parkinson's Disease: the NOPA ...	Parkinson Disease	Dietary Supplement: Nicotinamide Riboside;Drug: Placebo	Haukeland University Hospital	NULL	Recruiting	18 Years	N/A	All	400	N/A	Norway
3	NCT03816020 (ClinicalTrials.gov)	March 9, 2019	7/12/2018	NAD-supplementation in Drug naïve Parkinson's Disease	NAD-PARK: A Double-blinded Randomized Pilot Trial of NAD-supplementation in Drug naïve Parkinson's D ...	Parkinson Disease;Neurodegenerative Diseases	Dietary Supplement: Nicotinamide Riboside;Other: Placebo	Haukeland University Hospital	NULL	Completed	18 Years	N/A	All	30	N/A	Norway
4	NCT03865121 (ClinicalTrials.gov)	March 4, 2019	26/2/2019	Pilot Trial of Transnasal Nicotine in Parkinson Disease	Uncontrolled Pilot Trial of Transnasal Nicotine in Parkinson Disease	Parkinson Disease	Drug: Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY)	El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez	Howard University	Completed	60 Years	N/A	All	6	Phase 2	Mexico
5	NCT02452125 (ClinicalTrials.gov)	May 2015	20/5/2015	The Effects of Nicotine Chewing Gum in Parkinson's Disease	The Effects of Nicotine Chewing Gum on Acute Low Blood Pressure in Parkinson's Disease	Low Blood Pressure;Parkinsons Disease	Dietary Supplement: Nicotine gum	New York Institute of Technology	NULL	Completed	N/A	N/A	All	10	N/A	United States
6	JPRN-UMIN000016664	2015/03/01	01/03/2015	Effect of nicotine patch in Cognitive function improvement in Parkinson's disease	Effect of nicotinepatch in Cognitive function improvement in Parkinson's disease - Effect of nicotin ...	Parkinson's disease	nicotine patch	Department of Clinical Pharmacology and Neurology Ehime University graduated School of Medicine	NULL	Recruiting	Not applicable	Not applicable	Male and Female	20	Not selected	Japan
7	NCT01560754 (ClinicalTrials.gov)	October 2012	9/3/2012	Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease	A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying P ...	Parkinson's Disease	Drug: nicotine transdermal patch	James BOYD MD	Michael J. Fox Foundation for Parkinson's Research;Parkinson Study Group (PSG);International Parkins ...	Active, not recruiting	30 Years	N/A	Both	160	Phase 2	United States;Germany
8	EUCTR2010-020299-42-DE (EUCTR)	30/08/2011	26/04/2011	A study in U.S. and Germany to show if patients with an early stage of Parkinson's disease could be ...	A randomized, placebo-controlled, double-blind, multi-center trial to assess the disease-modifying p ...	Early PD subjects within 18 months of diagnosis and not expected to require dopamine agonist or levo ...	Trade Name: Nicotinell 17,5 mg/24-Stunden-Pflaster Product Name: Nicotinell Other descriptive name: NIC ...	Philipps-University Marburg	NULL	Not Recruiting			Female: yes Male: yes	160	Phase 2	United States;Germany
9	NCT01216904 (ClinicalTrials.gov)	October 2010	6/10/2010	Nicotine Treatment of Impulsivity in Parkinson's Disease	Nicotine Treatment of Impulsivity in Parkinson's Disease: A Pilot Study	Parkinson's Disease	Drug: nicotine patch;Drug: placebo	University of Vermont	Parkinson's Disease Foundation;The Parkinson Study Group	Recruiting	18 Years	N/A	Both	20	Phase 4	United States
10	NCT00957918 (ClinicalTrials.gov)	October 2009	11/8/2009	Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa ...	Randomized, Double-Blind, Parallel Group, Placebo Controlled Safety, Tolerability and Efficacy Study ...	Parkinson's Disease	Drug: nicotine;Other: placebo comparator	Neuraltus Pharmaceuticals, Inc.	NULL	Completed	30 Years	83 Years	Both	65	Phase 1/Phase 2	United States

First Previous1 2Next Last